Journal of Thoracic Oncology · 2012 · 677 citations · 53 references
MedicineOncologyPharmacologyMedical OncologyMolecular OncologyOncogenesLung Cancer PharmacotherapyOncogene AddictionOncogenic Signaling PathwaysOncology PharmacologyTyrosine Kinase InhibitorsDisease Progression ControlKinase Signaling InhibitorsLocal Ablative TherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentProtein Kinase InhibitorsTherapeutic Tyrosine Kinase Inhibitors
53
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Tony Mok, Yi‐Long Wu, Sumitra Thongprasert et al. · New England Journal of Medicine · 2009 · 8.2K citations · Full text
Medicine, Oncology, Pharmacology +13
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations
Medicine, Oncology, Pharmacology +13
Rafael Rosell, Enric Carcereny, Radj Gervais et al. · The Lancet Oncology · 2012 · 5.5K citations · Full text
Medicine, Oncology, Pharmacology +12
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations
Medicine, Oncology, Pharmacology +14
Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe et al. · The Lancet Oncology · 2009 · 4.1K citations
Medicine, Oncology, Pharmacology +15